Impacts of Post-Covid Condition (PCC) in Sweden: a cross-sectional observational survey study.

Publication date: May 12, 2026

The COVID-19 pandemic left many people with persistent health problems following a COVID-19 infection. Research on the condition better known as Post-Covid Condition (PCC) is still inconclusive, and few evidence-based treatments are currently available, although several studies report promising results. There are however people in need of treatment and support. To better understand what such help might entail, we conducted an online-based survey (n = 629, 82. 6% women) to examine the impact of PCC in Sweden and explore relationships among various variables using correlation analysis. Swedish-speaking adults with at least one persisting health problem after COVID-19 were included in the study. The survey included demographic and psychosocial variables, historic COVID-19 data, other clinical measures of psychological distress, satisfaction with life, and daily functioning impairment. Results indicate a substantial and heterogeneous impact of PCC in this sample. Participants reported an average of 10. 70 (SD = 5. 62) symptoms with the most frequently reported being fatigue (90. 9%, n = 507) and cognitive deficits (73. 3%, n = 409). The highest average symptom burden scores were reported for post-exertional malaise (PEM; M = 8. 37, SD = 1. 70) and fatigue (M = 8. 22, SD = 1. 77). Medication, self-help advice, and physiotherapy were the most frequently reported treatment modalities. Most participants reported their problems being unchanged or improved after treatment, but there were reports of worsening as well. Regarding psychological distress, participants reported mild anxiety, moderate depression, and subclinical but notable levels of sleeping problems. On average, daily functioning was substantially impaired by PCC and participants reported being “somewhat dissatisfied with life”. The correlational analyses revealed several significant correlations (|r| = 0. 11-0. 93, p

Open Access PDF

Concepts Keywords
Daily Adult
Online Aged
Pandemic Behavioral medicine
Sleeping COVID-19
Swedish COVID-19
Cross-Sectional Studies
Daily functioning
Fatigue
Female
Health impact
Humans
Long covid
Male
Middle Aged
Pandemic
Post-Covid Condition
Quality of Life
Satisfaction with life
Surveys and Questionnaires
Sweden
Young Adult

Semantics

Type Source Name
disease MESH Post-Covid Condition
drug DRUGBANK Factor IX Complex (Human)
disease MESH PCC
disease MESH COVID-19 pandemic
disease MESH infection
drug DRUGBANK Tropicamide
disease MESH included
disease MESH fatigue
disease MESH anxiety
pathway REACTOME Reproduction
drug DRUGBANK Polyethylene glycol
disease MESH allergies
disease MESH dizziness
pathway REACTOME Immune System
disease MESH tar
disease MESH CBT
drug DRUGBANK Trestolone
drug DRUGBANK Aspartame
disease MESH cam
disease MESH pus
disease MESH ics
disease MESH Generalized Anxiety Disorder
disease MESH insomnia
pathway REACTOME Translation
drug DRUGBANK Cysteamine
disease MESH bed
disease MESH brain fog
disease MESH memory loss
disease MESH abdominal pain
disease MESH dis
disease MESH asthma
pathway KEGG Asthma
drug DRUGBANK Methionine
disease MESH cognitive impairments
disease MESH Myalgic Encephalomyelitis
drug DRUGBANK Fenamole
drug DRUGBANK Ademetionine
drug DRUGBANK Coenzyme M
disease MESH chronic pain
disease MESH plan
disease MESH chronic conditions
disease MESH mul
disease MESH Syndrome
disease MESH Cda
drug DRUGBANK Flutamide
disease MESH Pain
disease MESH mental illness
disease MESH fibromyalgia
disease MESH musculoskeletal pain
disease MESH Cancer

Original Article

(Visited 4 times, 1 visits today)

Leave a Comment

Your email address will not be published. Required fields are marked *